Literature DB >> 10933691

E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.

S J Advani1, R R Weichselbaum, B Roizman.   

Abstract

The transition from G(1) to S phase in the cell cycle requires sequential activation of cyclin-dependent kinase 4 (cdk4) and cdk2, which phosphorylate the retinoblastoma protein, causing the release of E2F. Free E2F upregulates the transcription of genes involved in S phase and cell cycle progression. Recent studies from this and other laboratories have shown that herpes simplex virus 1 stabilizes cyclin D3 early in infection and that early events in viral replication are sensitive to inhibitors of some cdks. On the other hand cdk2 is not activated. Here we report studies on the status of members of E2F family in cycling HEp-2 and HeLa cells and quiescent serum-starved, contact-inhibited human lung fibroblasts. The results show that (i) at 8 h postinfection or thereafter, E2F-1 and E2F-5 were posttranslationally modified and/or translocated from nucleus to the cytoplasm, (ii) E2F-4 was hyperphophorylated, and (iii) overall, E2F binding to cognate DNA sites was decreased at late times after infection. These results concurrent with those cited above indicate that late in infection activation of S-phase genes is blocked both by posttranslational modification and translocation of members of E2F family to inactive compartments and by the absence of active cdk2. The observation that E2F were also posttranslationally modified in quiescent human lung fibroblasts that were not in S phase at the time of infection suggests that specific viral gene products are responsible for modification of the members of E2F family and raises the possibility that in infected cells, activation of the S phase gene is an early event in viral infection and is then shut off at late times. This is consistent with the timing of stabilization of cyclin D3 and the events blocked by inhibitors of cdks.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933691      PMCID: PMC112314          DOI: 10.1128/jvi.74.17.7842-7850.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes.

Authors:  J van der Sman; N S Thomas; E W Lam
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

2.  Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.

Authors:  H Müller; M C Moroni; E Vigo; B O Petersen; J Bartek; K Helin
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  E2F-1 functions in mice to promote apoptosis and suppress proliferation.

Authors:  S J Field; F Y Tsai; F Kuo; A M Zubiaga; W G Kaelin; D M Livingston; S H Orkin; M E Greenberg
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

4.  Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3.

Authors:  Y Kawaguchi; C Van Sant; B Roizman
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation.

Authors:  M A Ikeda; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

7.  Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

Authors:  M Li; H Lee; D W Yoon; J C Albrecht; B Fleckenstein; F Neipel; J U Jung
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

8.  Novel phosphorylated forms of E2F-1 transcription factor bind to the retinoblastoma protein in cells overexpressing an E2F-1 cDNA.

Authors:  X H Yang; T L Sladek
Journal:  Biochem Biophys Res Commun       Date:  1997-03-17       Impact factor: 3.575

9.  Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription.

Authors:  M J Margolis; S Pajovic; E L Wong; M Wade; R Jupp; J A Nelson; J C Azizkhan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  16 in total

1.  The role of cdc2 in the expression of herpes simplex virus genes.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1.

Authors:  Sunil J Advani; Lizette O Durand; Ralph R Weichselbaum; Bernard Roizman
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Herpes simplex virus 1 induces cytoplasmic accumulation of TIA-1/TIAR and both synthesis and cytoplasmic accumulation of tristetraprolin, two cellular proteins that bind and destabilize AU-rich RNAs.

Authors:  Audrey Esclatine; Brunella Taddeo; Bernard Roizman
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 5.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Pocket protein p130/Rb2 is required for efficient herpes simplex virus type 1 gene expression and viral replication.

Authors:  G L Ehmann; H A Burnett; S L Bachenheimer
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Analysis of the cell cycle regulatory protein (E2F1) after infection of cultured cells with bovine herpesvirus 1 (BHV-1) or herpes simplex virus type 1 (HSV-1).

Authors:  Aspen Workman; Clinton Jones
Journal:  Virus Res       Date:  2011-05-23       Impact factor: 3.303

8.  cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factor.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry.

Authors:  Iain J MacLeod; Tony Minson
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

10.  Role of activating transcription factor 3 in the synthesis of latency-associated transcript and maintenance of herpes simplex virus 1 in latent state in ganglia.

Authors:  Minfeng Shu; Te Du; Grace Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.